HCA Healthcare reported a robust fourth-quarter net income of $1.88 billion, exceeding expectations and driving a notable rise in their share price. While the company enjoyed strong revenue growth fueled by increasing admissions, it faces projected losses of up to $900 million due to potential subsidy lapses and declining Medicaid payments. In response to these challenges, HCA has authorized a $10 billion share repurchase plan and raised its quarterly dividend, while maintaining a positive outlook for 2026.